tirzepatide mecanismo de acción The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity Tirzepatide y diabetes: en camino

The FDA regulates medications to ensure their safety and efficacy before they can be marketed and prescribed to patients

Your journey to optimal health starts HERE

And that's how we made drugs for centuries

Medicare may cover certain bariatric surgeries

While these medications generally are well tolerated, some patients may experience symptoms that require discontinuation

The aim of this prespecified analysis was to evaluate the impact of semaglutide on liver enzymes and suspected MASLD in patients from the SELECT trial, and to explore the CV benefits of semaglutide in a subgroup at risk for substantial fibrosis as defined by FIB-4